Literature DB >> 17853477

Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy.

Nadia Stefanova1, Markus Reindl, Manuela Neumann, Philipp J Kahle, Werner Poewe, Gregor K Wenning.   

Abstract

The role of microglial activation in multiple system atrophy (MSA) was investigated in a transgenic mouse model featuring oligodendroglial alpha-synuclein inclusions and loss of midbrain dopaminergic neurons by means of histopathology and morphometric analysis. Our findings demonstrate early progressive microglial activation in substantia nigra pars compacta (SNc) associated with increased expression of iNOS and correlating with dopaminergic neuronal loss. Suppression of microglial activation by early long-term minocycline treatment protected dopaminergic SNc neurons. The results suggest that oligodendroglial overexpression of alpha-synuclein may induce neuroinflammation related to nitrosive stress which is likely to contribute to neurodegeneration in MSA. Further, we detected increased toll-like receptor 4 immunoreactivity in both transgenic mice and MSA brains indicating a possible signaling pathway in MSA which needs to be further studied as a candidate target for neuroprotective interventions. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853477     DOI: 10.1002/mds.21671

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  98 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter.

Authors:  James D Mills; Jieqiong Chen; Woojin S Kim; Paul D Waters; Avanita S Prabowo; Eleonora Aronica; Glenda M Halliday; Michael Janitz
Journal:  Neurogenetics       Date:  2015-03-29       Impact factor: 2.660

3.  Insulin resistance and exendin-4 treatment for multiple system atrophy.

Authors:  Fares Bassil; Marie-Hélène Canron; Anne Vital; Erwan Bezard; Yazhou Li; Nigel H Greig; Seema Gulyani; Dimitrios Kapogiannis; Pierre-Olivier Fernagut; Wassilios G Meissner
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

Review 4.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

5.  Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.

Authors:  Mari H Savolainen; Katrina Albert; Mikko Airavaara; Timo T Myöhänen
Journal:  Exp Brain Res       Date:  2017-04-24       Impact factor: 1.972

6.  Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.

Authors:  Ashley D Reynolds; David K Stone; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Bladder dysfunction in a transgenic mouse model of multiple system atrophy.

Authors:  Mathieu Boudes; Pieter Uvin; Silvia Pinto; Thomas Voets; Clare J Fowler; Gregor K Wenning; Dirk De Ridder; Nadia Stefanova
Journal:  Mov Disord       Date:  2013-02-20       Impact factor: 10.338

8.  Screening of Toll-like receptors expression in multiple system atrophy brains.

Authors:  Tomasz Brudek; Kristian Winge; Tina Klitmøller Agander; Bente Pakkenberg
Journal:  Neurochem Res       Date:  2013-03-23       Impact factor: 3.996

9.  Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy.

Authors:  Noriyuki Shibata; Yuri Inose; Sono Toi; Atsuko Hiroi; Tomoko Yamamoto; Makio Kobayashi
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

10.  Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.

Authors:  Sylvia Stemberger; Werner Poewe; Gregor K Wenning; Nadia Stefanova
Journal:  Exp Neurol       Date:  2010-05-21       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.